LANKENAU INSTITUTE FOR MEDICAL RESEARCH
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jan 30, 2018 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 229 Total Citation Count
- Apr 06, 2001 Earliest Filing
- 8 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0190,789 Methods and Compositions for the Treatment of Ocular Diseases and DisordersApr 10, 15Jul 06, 17[A61K, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9766226 Methods and kits for measuring toxicity and oxidative stress in live cellsMar 27, 14Sep 19, 17[C12Q, G01N]
9446007 Methods for maintaining or improving health, well-being and/or a physiological function in a subjectMar 30, 15Sep 20, 16[A61K, A01N, A61P]
9273133 Compositions and methods for the treatment and prevention of lens fibrotic diseasesDec 04, 09Mar 01, 16[A61K, C07K]
8697391 Method of determining cell number or viability using hydroxyethyldisulfideMay 14, 10Apr 15, 14[C12Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0183,388 Novel IDO Inhibitors and Methods of Use ThereofAbandonedFeb 26, 13Jul 18, 13[A61K, C07D]
6872517 Early diagnosis of cancerous and precancerous conditions by leakage of signature peptides and carbohydrates into the bloodstreamExpiredMay 10, 01Mar 29, 05[C12Q, C12P, G01N]
2004/0219,582 Single nucleotide polymorphism in the FGF-3 gene and methods of use thereofAbandonedMar 11, 04Nov 04, 04[C07H, C12Q, C12N]
6753422 Odc allelic analysis method for assessing carcinogenic susceptibilityExpiredJul 24, 01Jun 22, 04[C07H]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.